KEGG   PATHWAY: bbis05216
Entry
bbis05216                   Pathway                                
Name
Thyroid cancer - Bison bison bison (American bison)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
bbis05216  Thyroid cancer
bbis05216

Organism
Bison bison bison (American bison) [GN:bbis]
Gene
104997328  RET; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
104988173  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
104999019  NCOA4; nuclear receptor coactivator 4 [KO:K09289]
104987347  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
104987441  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
104994615  tropomyosin alpha-3 chain-like isoform X1 [KO:K09290]
104994681  tropomyosin alpha-3 chain-like isoform X1 [KO:K09290]
105002326  tropomyosin alpha-3 chain-like [KO:K09290]
104998060  TPR; nucleoprotein TPR [KO:K09291]
104990062  TFG; protein TFG isoform X1 [KO:K09292]
105003692  HRAS; GTPase HRas [KO:K02833]
104981582  NRAS; GTPase NRas [KO:K07828]
105000225  KRAS; GTPase KRas isoform X1 [KO:K07827]
104999381  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
104984678  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
104979900  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
104986748  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
104995620  mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
104984403  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
105004745  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
104986307  photoreceptor-specific nuclear receptor-like [KO:K08524]
104988000  hepatocyte nuclear factor 4-alpha-like [KO:K08524]
104994893  RXRB; retinoic acid receptor RXR-beta [KO:K08525]
104997302  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
104990761  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
104994949  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
104992057  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
105005583  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
104996168  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
104995631  BAX; apoptosis regulator BAX [KO:K02159]
104994906  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
104990347  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
104994135  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
104996661  CDH1; cadherin-1 [KO:K05689]
104985336  CTNNB1; catenin beta-1 [KO:K02105]
104991933  TCF7; transcription factor 7 [KO:K02620]
105004594  TCF7L1; transcription factor 7-like 1 [KO:K04490]
105002610  TCF7L2; transcription factor 7-like 2 [KO:K04491]
105002090  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
104991741  MYC; myc proto-oncogene protein [KO:K04377]
104987056  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
bbis03320  PPAR signaling pathway
bbis04010  MAPK signaling pathway
bbis04115  p53 signaling pathway
bbis04310  Wnt signaling pathway
bbis04520  Adherens junction
KO pathway
ko05216   
LinkDB

DBGET integrated database retrieval system